PLUT and lung adenocarcinoma: For instance, promoter hypermethylation of the lncRNA PLUT was significantly associated with shorter relapse-free survival of lung adenocarcinoma [37], and hypermethylated ZNF667-AS1 was correlated with ESCC patients’ survival [38].